AKT1 and breast cancer: Vasudevan et al. [8] reported that a subset of breast cancer cell lines with mutations in PIK3CA displayed a reduced dependence on Akt for tumorigenicity, and instead relied on PDK1-dependent activation of another AGC kinase, SGK-3.